Home » Topics » Regulatory » Patents

Patents
RSS

Yuma Therapeutics and The Brigham and Women's Hospital develop HSP90 inhibitors

Jan. 5, 2016

Merck & Co. patents nAChR alpha7 PAMs

Jan. 5, 2016

Incyte patents PI3Kdelta inhibitors

Jan. 4, 2016

Bristol-Myers Squibb reports development of NS5B inhibitors

Dec. 31, 2015

GlaxoSmithKline describes STING modulators

Dec. 31, 2015

Bristol-Myers Squibb patents MGAT2 inhibitors

Dec. 31, 2015

Shionogi reports development of antifungal agents

Dec. 30, 2015

Takeda Pharmaceutical divulges muscarinic M1 PAMs

Dec. 30, 2015

Adamed develops p53-MDM2 interaction inhibitors

Dec. 30, 2015

Kyoto Pharmaceutical Industries reports napabucasin prodrugs

Dec. 30, 2015

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...